Stehlin Foundation for Cancer Research was founded in 1969 by Dr. John S. Stehlin, Jr. – a brilliant surgical oncologist with empathy for his patients and a vision to combine research and medicine to improve cancer treatment.
Dr. Stehlin recruited and worked along side a talented group of researchers and clinical staff to develop novel therapies and procedures that would change the lives of people with cancer forever. Dr. Stehlin retired from practice in 2002, but his legacy of compassionate care is as active as ever.
Today, CHRISTUS Stehlin Foundation continues to advance human cancer research in a world class laboratory. Its purpose is to conduct cancer research that can be applied directly to improving patient treatment. All Foundation research is clinically oriented.
Through exciting breakthroughs in cancer drug development and treatment, Dr. Stehlin’s vision lives on.
Cancer research is a complex undertaking requiring dedication, imagination, and optimism. CHRISTUS Stehlin Foundation for Cancer Research has pioneered anticancer drugs and treatments for more than 40 years.
Keep up on the latest developments in Cancer Research and Foundation News by visiting our News Page.
We post news of upcoming events and the latest articles and papers about cancer research to keep you informed of both Foundation happenings and the broader research and support community.
The Foundation's world class research programs exist only with the financial support of interested individuals, private foundations, and corporations. You can help: